Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma

被引:10
作者
Li, Na [1 ]
Zhang, Li [1 ]
Song, Hao-lan [2 ]
Zhang, Jing [1 ]
Weng, Hua-wei [1 ]
Zou, Li-qun [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Med Oncol, Canc Ctr,State Key Lab Biotherapy, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
关键词
Natural killer T cell; non-Hodgkin lymphoma; absolute lymphocyte count; absolute monocyte count; NON-HODGKIN-LYMPHOMA; PERIPHERAL T-CELL; SURVIVAL; RITUXIMAB; MODEL; INDEX; CHEMOTHERAPY; MULTICENTER; EPIDEMIOLOGY; LYMPHOPENIA;
D O I
10.1177/1010428317705503
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasal-type, extranodal natural killer/T-cell lymphoma is a heterogeneous disorder with poor prognosis, requiring risk stratification in this population. The combined value of baseline absolute lymphocyte count and absolute monocyte count provided prognostic information in some malignancies. However, the evidence requires validation in extranodal natural killer/T-cell lymphoma. Aiming to investigate the prognostic significance of absolute lymphocyte count/absolute monocyte count ratio and absolute lymphocyte count/absolute monocyte count prognostic score for extranodal natural killer/T-cell lymphoma, a retrospective research was carried out. A total of 264 patients with newly diagnosed extranodal natural killer/T-cell lymphoma were analyzed in this study. The patients' absolute lymphocyte count and absolute monocyte count tested at initial diagnosis were collected. Receiver operating curve analysis showed that the optimal cut-off values for absolute lymphocyte count and absolute monocyte count were 1.0 x 10(9) and 0.5 x 10(9)L(-1), respectively, and for absolute lymphocyte count/absolute monocyte count ratio was 2.85. After a median follow-up of 27 months (range 1-87 months), the 3-year overall survival and progression-free survival was 75.4% and 67.6%, respectively. Patients with absolute lymphocyte count/absolute monocyte count ratio 2.85 had better 3-year overall survival and progression-free survival than those with absolute lymphocyte count/absolute monocyte count ratio <2.85 (p < 0.001). According to absolute lymphocyte count/absolute monocyte count prognostic score, significant difference has been noticed in 3-year overall survival and progression-free survival (p < 0.001) and high absolute lymphocyte count/absolute monocyte count prognostic score was associated with poorer survival. The International Prognostic Index and Korean Prognostic Index were used for prognosis and showed no significant difference. When adding absolute lymphocyte count/absolute monocyte count ratio and absolute lymphocyte count/absolute monocyte count prognostic score to the International Prognostic Index and Korean Prognostic Index model, additional prognostic information was found. These results suggest that absolute lymphocyte count/absolute monocyte count ratio and absolute lymphocyte count/absolute monocyte count prognostic score might be useful prognostic factors in extranodal natural killer/T-cell lymphoma.
引用
收藏
页数:11
相关论文
共 42 条
  • [1] The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Aoki, Kazunari
    Tabata, Sumie
    Yonetani, Noboru
    Matsushita, Akiko
    Ishikawa, Takayuki
    [J]. ACTA HAEMATOLOGICA, 2013, 130 (04) : 242 - 246
  • [2] Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
    Au, Wing-yan
    Weisenburger, Dennis D.
    Intragumtornchai, Tanin
    Nakamura, Shigeo
    Kim, Won-Seog
    Sng, Ivy
    Vose, Julie
    Armitage, James O.
    Liang, Raymond
    [J]. BLOOD, 2009, 113 (17) : 3931 - 3937
  • [3] Angiocentric nasal T/natural killer cell lymphoma:: a single centre study of prognostic factors in 108 patients
    Avilés, A
    Díaz, NR
    Neri, N
    Cleto, S
    Talavera, A
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (04): : 215 - 220
  • [4] The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP
    Batty, Nicolas
    Ghonimi, Elham
    Feng, Lei
    Fayad, Luis
    Younes, Anas
    Rodriguez, Maria Alma
    Romaguera, Jorge Enrique
    McLaughlin, Peter
    Samaniego, Felipe
    Kwak, Larry W.
    Hagemeister, Fredrick B., Jr.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (01) : 15 - 18
  • [5] Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas
    Behl, Deepti
    Ristow, Kay
    Markovic, Svetomir N.
    Witzig, Thomas E.
    Habermann, Thomas M.
    Colgan, Joseph P.
    Inwards, David J.
    White, William L.
    Ansell, Stephen M.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Porrata, Luis F.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) : 409 - 415
  • [6] Nasal Natural Killer/T Cell Lymphoma
    Bhatkule, Milind Anil
    Dhawle, Manjusha Shripad
    Kumbhakarna, N. R.
    Bindu, Rajan S.
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 : S292 - S293
  • [7] New prognostic model for extranodal natural killer/T cell lymphoma, nasal type
    Cai, Qingqing
    Luo, Xiaolin
    Zhang, Guanrong
    Huang, Huiqiang
    Huang, Hui
    Lin, Tongyu
    Jiang, Wenqi
    Xia, Zhongjun
    Young, Ken H.
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (09) : 1541 - 1549
  • [8] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
    Cheson, BD
    Horning, SJ
    Coiffier, B
    Shipp, MA
    Fisher, RI
    Connors, JM
    Lister, TA
    Vose, J
    Grillo-López, A
    Hagenbeek, A
    Cabanillas, F
    Klippensten, D
    Hiddemann, W
    Castellino, R
    Harris, NL
    Armitage, JO
    Carter, W
    Hoppe, R
    Canellos, GP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1244 - 1253
  • [9] Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
    Cheung, MMC
    Chan, JKC
    Lau, WH
    Ngan, RKC
    Foo, WWL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01): : 182 - 190
  • [10] Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
    Chim, CS
    Ma, SY
    Au, WY
    Choy, C
    Lie, AKW
    Liang, R
    Yau, CC
    Kwong, YL
    [J]. BLOOD, 2004, 103 (01) : 216 - 221